Product Theater: Medimaps - Integrating TBS into Clinical Practice

This session duration is 40 minutes.

Developed by Medimaps Group, TBS Osteo is an FDA and CE mark approved solution which is considered gold standard in bone micro-architecture assessment. It computes a Trabecular Bone Score (TBS), which provides useful clinical information on microarchitectural deterioration of bone tissue, thereby improving the accuracy of osteoporosis identification. Moreover, TBS has now 4 new dedicated CPT codes for US reimbursement.

Learning Objectives:

  • Understand the clinical benefits of TBS
  • How to use TBS in combination with BMD and FRAX in clinical practice
  • How TBS can help fine-tune treatment decisions
  • Learn about the reimbursement for TBS

E. Michael Lewiecki, MD, FACP, FACE, CCD

Director

New Mexico Clinical Research & Osteoporosis Center, Inc.

E. Michael Lewiecki, MD, CCD, FACP, FACE, FASBMR, is Director of New Mexico Clinical Research & Osteoporosis Center and Director of Bone Health TeleECHO at University of New Mexico Health Sciences Center in Albuquerque, NM. His is a consultant in osteoporosis and metabolic bone disease, supervisor and interpreter of bone density studies, and an educator with a special interest in the evaluation and treatment of osteoporosis and metabolic bone diseases. He has been principal investigator for many osteoporosis clinical trials and is author of over 300 publications in peer-reviewed medical journals, as well as books, book chapters, and online publications on osteoporosis. Dr. Lewiecki is past-president of the International Society for Clinical Densitometry (ISCD) and current president of the Osteoporosis Foundation of New Mexico (OFNM). He is an editor for Osteoporosis International, and is on the editorial boards of the Journal of Bone and Mineral Research and the Journal of Clinical Densitometry. He has received national and international awards that include the 2021 “Dr. John P. Bilezikian ISCD Global Leadership Award” and the 2021 “Lawrence G. Raisz Memorial Lecture Award” with the Bone Health & Osteoporosis Foundation. Dr. Lewiecki is the program director of the annual Santa Fe Bone Symposium, the flagship activity of the OFNM.

Disclosures: 

Amgen (Self) : Consultant (Status: Ongoing), Research Support (Status: Ongoing), Speaker's Bureau / Teaching Engagements (Status: Ongoing); Radius (Self) : Research Support (Status: Ongoing)

Andrea J. Singer, MD, FACP CCD

Director of Women’s Primary Care, Director of the Bone Densitometry Program, and Medical Director of the Fracture Liaison Service focusing on secondary fracture prevention

MedStar Georgetown University Hospital in Washington, DC

Andrea J. Singer, MD, FACP CCD, is Director of Women’s Primary Care, Director of the Bone Densitometry Program, and Medical Director of the Fracture Liaison Service focusing on secondary fracture prevention at MedStar Georgetown University Hospital in Washington, DC. She holds a dual appointment in the Departments of Medicine and Obstetrics at Gynecology at Georgetown University Medical Center, Washington, DC. Dr. Singer earned her medical degree at Albert Einstein College of Medicine in Bronx, NY. She completed her internship and residency, including serving as Chief Resident, at Georgetown University Medical Center in Washington, DC. Dr. Singer is Chief Medical Officer at the Bone Health and Osteoporosis Foundation (formerly the National Osteoporosis Foundation) and has been a member of the Board of Trustees. She co-chairs the annual Interdisciplinary Symposium on Osteoporosis for BHOF. Dr Singer has been the principal investigator for several clinical trials and quality improvement projects in osteoporosis and bone health. Her areas of interest include women’s health, osteoporosis management, economic impact of osteoporosis, secondary fracture prevention, menopause, and sexual health, and she has authored numerous publications in in peer-reviewed journals including Mayo Clinic Proceedings, Osteoporosis International, Journal of Bone and Mineral Research, Current Medical Research Opinion, and Journal of Bone and Joint Surgery, among others, as well as book chapters and online publications. She is Section Editor for Bone Health in Journal of Women’s Health, a member of the Editorial Board of Osteoporosis: Clinical Updates, and Reviewer for Osteoporosis International, American Journal of Obstetrics and Gynecology, and Journal of Sexual Medicine.

Disclosures: No relationships to disclose.

Didier Hans, PhD (Moderator)

Head of Research & Development in medical imaging

Lausanne University

Prof. Didier Hans, Ph.D., MBA. is the Head of Research and Development in the Bone and Joint Department at the Interdisciplinary Center of Bone Disease at Lausanne University Hospital. Prof. Hans has extensive experience in DXA, bone macro- & microarchitecture, ultrasound imaging techniques as well as Body composition assessment. Prof. Hans served as the 1st non North American International Society of Clinical Densitometry (ISCD) President and remained an active member of the ISCD Board of Directors as well as a member of the scientific advisory committee of the International Osteoporosis Foundation (IOF). He has authored more than 300 articles (h- index 74), over 30 book chapters and serves as a reviewer and/or member of the editorial board for more than 15 international scientific journals. As a musculoskeletal expert, Prof. Hans has been invited to present at over 600 conferences and events on topics including osteoporosis, bone quality and bone fractures, among other subjects. Prof. Hans was the recipient of many awards & recognitions including the ISCD Researcher of the Year Award for his global work on Trabecular Bone Score (TBS), Dr. John P. Bilezikian ISCD Global Leadership Award as well as the ISCD clinician of the year award for distinguished services to the field of bone densitometry. Prior his current position, Pr. Hans was during 10 years the Head of the R&D in the Radiology Department, Bone and Body composition laboratory at University of Geneva, Switzerland. Previously, he was the Director of the Quality Assurance Center for Clinical Research and the associate director of R&D for the ultrasound unit at the Osteoporosis and Arthritis Research Group (OARG) at UCSF, San Francisco, USA (directed by Prof Harry K. Genant). At earlier stage, he was the director of both Bone Densitometry and New Technologies Department and Quality Assurance Center at the Centre d’Epidémiologie des Ostéoporoses in Lyon, France (directed by Profs Pierre J. Meunier and Pierre D. Delmas).

Disclosures: 

medimaps group (Self) : Board Member/Advisory Panel (Status: Ongoing), part time employee (Status: Ongoing), Shareholder (Status: Ongoing)

Key:

Complete
Failed
Available
Locked
Recorded Archive
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin.
Session
03/31/2022 at 1:20 PM (EDT)   |  40 minutes
03/31/2022 at 1:20 PM (EDT)   |  40 minutes